283 related articles for article (PubMed ID: 37234334)
21. Alternation of β-catenin and CD44s Immunoexpression in Different Histopathological Grades of Oral Squamous Cell Carcinoma.
Zargaran M
Asian Pac J Cancer Prev; 2020 May; 21(5):1181-1185. PubMed ID: 32458620
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of Tumor-associated Tissue Eosinophilia in Different Stages of Oral Squamous Cell Carcinoma using Special Stains: An in vitro Histopathological Study.
Vaibhav SL; Priya PL; Sonam CK; Supriya K; Garima Y; Sabeer S; Juvale P; Javir G
J Contemp Dent Pract; 2018 May; 19(5):579-586. PubMed ID: 29807970
[TBL] [Abstract][Full Text] [Related]
23. Quality of Life Assessment With European Organisation for Research and Treatment of Cancer Questionnaire (Head and Neck Module 43) and Its Clinicopathological Correlation Among Patients Treated for Oral Squamous Cell Carcinoma: An Exploratory Study.
Ramalingam K; Krishnan M; Ramani P; Muthukrishnan A
Cureus; 2023 Feb; 15(2):e34650. PubMed ID: 36895543
[TBL] [Abstract][Full Text] [Related]
24. Gene expression profiling for guiding adjuvant chemotherapy decisions in women with early breast cancer: an evidence-based and economic analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2010; 10(23):1-57. PubMed ID: 23074401
[TBL] [Abstract][Full Text] [Related]
25. The study of E-cadherine and CD44 immunoexpression in oral squamous cell carcinoma.
Simionescu C; Mărgăritescu C; Surpăţeanu M; Mogoantă L; Zăvoi R; Ciurea R; Surlin P; Stepan A
Rom J Morphol Embryol; 2008; 49(2):189-93. PubMed ID: 18516325
[TBL] [Abstract][Full Text] [Related]
26. Moesin expression by tumor cells is an unfavorable prognostic biomarker for oral cancer.
Barros FBA; Assao A; Garcia NG; Nonogaki S; Carvalho AL; Soares FA; Kowalski LP; Oliveira DT
BMC Cancer; 2018 Jan; 18(1):53. PubMed ID: 29310601
[TBL] [Abstract][Full Text] [Related]
27. Glut-1 as a prognostic biomarker in oral squamous cell carcinoma.
Harshani JM; Yeluri S; Guttikonda VR
J Oral Maxillofac Pathol; 2014; 18(3):372-8. PubMed ID: 25948991
[TBL] [Abstract][Full Text] [Related]
28. Prognostic Implication of Survivin Expression in Oral Squamous Cell Carcinoma-An Immunohistochemical Study.
Ajithkumar M; Murali CR; Vani NV
J Contemp Dent Pract; 2019 May; 20(5):577-581. PubMed ID: 31316021
[TBL] [Abstract][Full Text] [Related]
29. Immunoexpression of Metallothionein in Oral Squamous Cell Carcinoma.
Dumpala RK; Guttikonda VR
J Maxillofac Oral Surg; 2015 Dec; 14(4):914-9. PubMed ID: 26604463
[TBL] [Abstract][Full Text] [Related]
30. Tumour budding activity and cell nest size determine patient outcome in oral squamous cell carcinoma: proposal for an adjusted grading system.
Boxberg M; Jesinghaus M; Dorfner C; Mogler C; Drecoll E; Warth A; Steiger K; Bollwein C; Meyer P; Wolff KD; Kolk A; Weichert W
Histopathology; 2017 Jun; 70(7):1125-1137. PubMed ID: 28122134
[TBL] [Abstract][Full Text] [Related]
31. Differences among oral carcinomas arising de novo from those associated with oral potentially malignant disorders: a systematic review and meta-analysis.
Piemonte ED; Gilligan GM; Garola F; Lazos JP; Panico RL; Normando AGC; Santos-Silva AR; Warnakulasuriya S
Oral Surg Oral Med Oral Pathol Oral Radiol; 2024 Jun; 137(6):613-631. PubMed ID: 38609795
[TBL] [Abstract][Full Text] [Related]
32. Immunohistochemical assessment of E-cadherin and β-catenin in the histological differentiations of oral squamous cell carcinoma.
Zaid KW
Asian Pac J Cancer Prev; 2014; 15(20):8847-53. PubMed ID: 25374218
[TBL] [Abstract][Full Text] [Related]
33. Shifts in cellular localization of moesin in normal oral epithelium, oral epithelial dysplasia, verrucous carcinoma and oral squamous cell carcinoma.
Kobayashi H; Sagara J; Masumoto J; Kurita H; Kurashina K; Taniguchi S
J Oral Pathol Med; 2003 Jul; 32(6):344-9. PubMed ID: 12787041
[TBL] [Abstract][Full Text] [Related]
34. Comprehensive Analysis of Oral Squamous Cell Carcinomas: Clinical, Epidemiological, and Histopathological Insights With a Focus on Prognostic Factors and Survival Time.
Fatima J; Fatima E; Mehmood F; Ishtiaq I; Khan MA; Khurshid HMS; Kashif M
Cureus; 2024 Feb; 16(2):e54394. PubMed ID: 38505442
[TBL] [Abstract][Full Text] [Related]
35. Association of salivary Cathepsin B in different histological grades among patients presenting with oral squamous cell carcinoma.
Shabbir A; Waheed H; Ahmed S; Shaikh SS; Farooqui WA
BMC Oral Health; 2022 Mar; 22(1):63. PubMed ID: 35260133
[TBL] [Abstract][Full Text] [Related]
36. Ki-67 Prognostic Value in Different Histological Grades of Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma.
Takkem A; Barakat C; Zakaraia S; Zaid K; Najmeh J; Ayoub M; Seirawan MY
Asian Pac J Cancer Prev; 2018 Nov; 19(11):3279-3286. PubMed ID: 30486632
[TBL] [Abstract][Full Text] [Related]
37. Prognostic Relevance of Lymphatic Vessel Density in Squamous Cell Carcinomas of the Oral Cavity: A Systematic Review and Meta-Analysis.
Tandon A; Sandhya K; Singh NN; Kumar A
Head Neck Pathol; 2022 Dec; 16(4):1185-1194. PubMed ID: 35904748
[TBL] [Abstract][Full Text] [Related]
38. Clinical significance of cellular distribution of moesin in patients with oral squamous cell carcinoma.
Kobayashi H; Sagara J; Kurita H; Morifuji M; Ohishi M; Kurashina K; Taniguchi S
Clin Cancer Res; 2004 Jan; 10(2):572-80. PubMed ID: 14760079
[TBL] [Abstract][Full Text] [Related]
39. Correlation of Clinical and Pathological TNM Staging With Histopathological Grading in Oral Squamous Cell Carcinoma.
Tehzeeb H; Hande A; Patil S; Sonone A; Pakhale A; Chavhan A
Cureus; 2024 May; 16(5):e60912. PubMed ID: 38910661
[TBL] [Abstract][Full Text] [Related]
40. A systematic review of evidence on malignant spinal metastases: natural history and technologies for identifying patients at high risk of vertebral fracture and spinal cord compression.
Sutcliffe P; Connock M; Shyangdan D; Court R; Kandala NB; Clarke A
Health Technol Assess; 2013 Sep; 17(42):1-274. PubMed ID: 24070110
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
